🇺🇸 FDA
Patent

US 10006052

Laglidadg homing endonuclease cleaving the C-C chemokine receptor type-5 (CCR5) gene and uses thereof

granted A61KA61K38/465A61K40/11

Quick answer

US patent 10006052 (Laglidadg homing endonuclease cleaving the C-C chemokine receptor type-5 (CCR5) gene and uses thereof) held by PRECISION GENOME ENGINEERING, INC. expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PRECISION GENOME ENGINEERING, INC.
Grant date
Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K38/465, A61K40/11, A61K40/46, A61P